JHS Svendgaard Laboratories Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting

JHS Svendgaard's board approved Q3 FY26 consolidated results: a ₹0.79 Cr net profit, turning around from a ₹1.84 Cr loss YoY. They also sanctioned converting 1.8 million warrants to equity, impacting paid-up capital. Funds are being utilized for projects and capex.